Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James D Berry

Showing results (51-60 of 176) with videos related to

Pageof 18
Sort By:
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|August 28, 2024
Body mass index is lower in asymptomatic <i>C9orf72</i> expansion carriers but not in <i>SOD1</i> pathogenic variant carriers compared to gene negativesIkjae Lee, Mark A Garret, Joanne Wuu, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|May 31, 2018
Expanded autologous regulatory T-lymphocyte infusions in ALS: A phase I, first-in-human studyJason R Thonhoff, David R Beers, Weihua Zhao, et al.
Journal of Medical Internet Research|December 8, 2021
Recruitment of Patients With Amyotrophic Lateral Sclerosis for Clinical Trials and Epidemiological Studies: Descriptive Study of the National ALS Registry's Research Notification MechanismPaul Mehta, Jaime Raymond, Moon Kwon Han, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|October 28, 2022
The efficacy of acoustic-based articulatory phenotyping for characterizing and classifying four divergent neurodegenerative diseases using sequential motion ratesHannah P Rowe, Perman Gochyyev, Adam C Lammert, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|February 7, 2023
Epidemiology and economic burden of amyotrophic lateral sclerosis in the United States: a literature reviewJames D Berry, Marie Blanchard, Kerina Bonar, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|October 4, 2022
A revision to the United States national ALS registry's algorithm to improve Case-AscertainmentPaul Mehta, Jaime Raymond, Moon Han, et al.
BMJ Open|March 9, 2022
Protocol for psychometric evaluation of the Amyotrophic Lateral Sclerosis - Bulbar Dysfunction Index (ALS-BDI): a prospective longitudinal studyYana Yunusova, Ashley Waito, Carolina Barnett, et al.
Muscle & Nerve|July 29, 2022
Longitudinal comparison of the self-entry Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-RSE) and Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS) as outcome measures in people with amyotrophic lateral sclerosisStephen A Johnson, Katherine M Burke, Zoe A Scheier, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|November 2, 2020
The human gut microbiota in people with amyotrophic lateral sclerosisKatharine Nicholson, Kjetil Bjornevik, Galeb Abu-Ali, et al.
Frontiers in Neurology|January 23, 2023
Face and content validation of the amyotrophic lateral sclerosis-Bulbar dysfunction index (ALS-BDI)Yana Yunusova, Ashley Waito, Carolina Barnett Tapia, et al.
Pageof 18

Showing results (51-60 of 176) with videos related to

Sort By:
Pageof 18
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|August 28, 2024
Body mass index is lower in asymptomatic <i>C9orf72</i> expansion carriers but not in <i>SOD1</i> pathogenic variant carriers compared to gene negativesIkjae Lee, Mark A Garret, Joanne Wuu, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|May 31, 2018
Expanded autologous regulatory T-lymphocyte infusions in ALS: A phase I, first-in-human studyJason R Thonhoff, David R Beers, Weihua Zhao, et al.
Journal of Medical Internet Research|December 8, 2021
Recruitment of Patients With Amyotrophic Lateral Sclerosis for Clinical Trials and Epidemiological Studies: Descriptive Study of the National ALS Registry's Research Notification MechanismPaul Mehta, Jaime Raymond, Moon Kwon Han, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|October 28, 2022
The efficacy of acoustic-based articulatory phenotyping for characterizing and classifying four divergent neurodegenerative diseases using sequential motion ratesHannah P Rowe, Perman Gochyyev, Adam C Lammert, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|February 7, 2023
Epidemiology and economic burden of amyotrophic lateral sclerosis in the United States: a literature reviewJames D Berry, Marie Blanchard, Kerina Bonar, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|October 4, 2022
A revision to the United States national ALS registry's algorithm to improve Case-AscertainmentPaul Mehta, Jaime Raymond, Moon Han, et al.
BMJ Open|March 9, 2022
Protocol for psychometric evaluation of the Amyotrophic Lateral Sclerosis - Bulbar Dysfunction Index (ALS-BDI): a prospective longitudinal studyYana Yunusova, Ashley Waito, Carolina Barnett, et al.
Muscle & Nerve|July 29, 2022
Longitudinal comparison of the self-entry Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-RSE) and Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS) as outcome measures in people with amyotrophic lateral sclerosisStephen A Johnson, Katherine M Burke, Zoe A Scheier, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|November 2, 2020
The human gut microbiota in people with amyotrophic lateral sclerosisKatharine Nicholson, Kjetil Bjornevik, Galeb Abu-Ali, et al.
Frontiers in Neurology|January 23, 2023
Face and content validation of the amyotrophic lateral sclerosis-Bulbar dysfunction index (ALS-BDI)Yana Yunusova, Ashley Waito, Carolina Barnett Tapia, et al.
Pageof 18